Omega Design’s auto-indexing machine dispenses canister desiccants into a wide range of containers for pharmaceutical and nutraceutical applications.
Omega Design CDFI Canister Feeder
Omega Design’s CDFI Canister Feeder is an intermittent-motion machine for inserting desiccants or oxygen absorbers into a broad range of bottles, jars, tubes, and vials. The latest addition to the company’s IMPACT series of packaging equipment, the compact, low-cost unit can accommodate up to 100 containers per minute.
The CDFI Canister Feeder accurately dispenses single or multiple canister drops with a simple selector switch. It features a simple set-up and accepts canisters from all major manufacturers. The unit does not require bottle change parts and, with the appropriate tooling, can accommodate various size canisters from one to three grams. Changeover takes less than five minutes, and the machine can be supplied with a five-gallon canister reservoir or 10-gallon hopper with elevator. The CDFI Canister Feeder is built on a freestanding mobile frame for easy transport to conveying stations on factory floors.
The unit works as follows: operators load desiccants into the hopper reservoir, then adjust the machine for the ensuing bottle run. An elevator belt carries desiccants into a sorter, down a vertical chute, and onto a dispensing plate. The desired quantity is then dispensed automatically, and the Allen Bradley programmable logic controller verifies that desiccants have exited the machine.
Source: Omega Design
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.